Thirdly, LPS-mediated TLR4-AKT pathway upregulates the expression of Sox2, a stemness marker gene, thereby increasing the number of cancer stem cells (CSCs) of HCC (148). The gene discussed is TLR4; the disease is hepatocellular carcinoma.